![]() |
The Physicians Services Incorporated Foundation This site is primarily for individuals with an interest in the research programs of the Foundation |
Report on Granting Activities
May 1 to Agust 31, 2008
The Foundation approved grants with a total value of
$1,056,000 in the second quarter of 2008, for the following
projects:
Dr. M. Bhandari
McMaster University
Fixation using alternative implants for the treatment of hip
fractures (FAITH): An Ontario pilot study, a multi-centre
randomized pilot trial comparing sliding hip screws and
cancellous screws on revision surgery rates and quality of life
in the treatment of femoral neck fractures.
Hip fractures are associated with a 30% mortality rate and occur
in 36,000 Canadians annually, and the number of hip fractures is
likely to exceed 88,000 in Canada over the next forty years.
Experimental data suggests that cancellous screws offer greater
preservation of blood supply, while sliding hip screws provide
greater bio-mechanical stability to bending stresses. While both
arguments are persuasive, the impact of these biologic
alterations on outcomes are important to patients and offer more
compelling guidelines for clinical practice.
The objective of this study is to assess the feasibility of
conducting a large definitive trial investigating the revision
surgery rate and quality of life when cancellous screws versus
sliding hip screws fixation is performed in patients over 50
years of age with a femoral neck fracture.
M. M. Flavin
Queen's University
Negative effect of high temperature on brain inflammatory
response - a key factor in the cause of Cerebral Palsy.
Cerebral Palsy (CP) is linked to chorioamnionitis (ChA), a
peri-natal infection of fetal membranes, which is usually
accompanied by maternal fever. Strong epidemiological links
between maternal fever and CP also exist. These investigators
have recently carried out experiments showing that hyperthermia,
a surrogate for fever, alters the intensity of the brain's
inflammatory response.
The goal of this study is to determine if fever amplifies brain
inflammatory response of the fetus to infection, and whether this
results in brain damage. This study will clarify if hyperthemia,
in a setting of inflammation, contributes to brain cell death
during late fetal brain development.
Dr. R. McManus
Dr. D. Somerset
University of Western Ontario
Vitamin D and cytokine levels in women with and without
gestational diabetes.
Pregnancy, and particularly gestational diabetes (GDM), are
insulin resistant states; adipocytokines, inflammatory cytokines,
and vitamin D (VITD) are of interest for developing associations
with insulin resistant states. Evolving evidence also suggests
associations between VITD repletion status and various cytokine
patterns.
The objectives of this study include assessing VITD and cytokine
levels in maternal serum, arterial and venous cord blood in
pregnancies with and without GDM, and to seek relationships
between VITD, cytokine levels, maternal and fetal outcomes.
Documentation between VITD and cytokine levels in GDM may provide
insights into linkages between insulin resistance and chronic
inflammation, while also identifying potential VITD intervention
studies.
Dr. C. Cardella
Toronto General Hospital
Down-regulation of allosensitized B cells.
A large number of patients across Canada are unable to receive a
successful organ transplant because of high levels of a
destructive antibody in their circulation. This destructive
antibody remains elevated in blood for years and reduces access
to transplantation. It responds poorly to treatment, can damage
the transplanted organ, and reduces the likelihood of a
successful transplant. New information on the control and
down-regulation of this destructive antibody is needed.
The specific aim of this study is to demonstrate that a
regulatory antibody can be produced in the laboratory and in
animals, and that this regulatory antibody will neutralize the
effect of the destructive antibodies.
Control of this destructive antibody will lead to successful
kidney transplantation in persons who are currently denied the
opportunity of receiving a transplant, while also reducing the
adverse effects of the destructive antibody on transplanted
organs.
Dr. C. Craven
Toronto Rehabilitation Institute
Chronic pain and fractures after spinal cord injury (SCI):
impact on costs of care and quality of life.
Spinal cord injury (SCI) is a major catastrophic life event that
affects an individual's ability to move around their
home/community, manage their bladder and bowel functions, blood
pressure, body temperature, and ability to eat and breathe
independently. Secondary Health Conditions (SHC) are common after
SCI and incur costs to the patient (indirect) and healthcare
system (direct), while also affecting the person's Quality of
Life (QOL).
The objectives of this study include determining the affect of
SHC on QOL among a group of people with chronic SCI, while also
identifying and prospectively quantifying the associated
indirect/direct costs of specific SHC (fractures and chronic
pain) in 2008. The goal of this study is to minimize the economic
burden of SHC and improve QOL after SCI.
Dr. M. Fehlings
M. Shoichet, Ph.D
Toronto Western Hospital
Neuroprotection of the injured spinal cord using an
anti-apoptotic molecule delivered through a novel bioengineered
drug delivery system.
Spinal cord injury (SCI) is devastating for the affected
individual and a major financial burden for society. Current
therapies for SCI are minimally effective, thus improved
treatments are required. The mechanism of SCI involves a primary
injury followed by biochemical processes that cause delayed cell
death (apoptosis). These investigators have previously shown that
activation of a 'death receptor' on nerve cells (FasR) appear to
be a key cause of apoptosis after SCI; moreover, data suggests
that administration of a soluble form of FasR (sFasR) can inhibit
FasR activation, reduce apoptosis of nerve cells and improve
neurological recovery.
This study will further examine the hypothesis that inhibition of
FasR mediated apoptosis by sFasR, when delivered in a clinically
relevant post-injury time window, will promote functional and
neuroanatomical recovery after SCI.
The objectives of this study are to optimize the drug delivery
system for sFasR, determine the most effective and clinically
relevant time window for administration, and elucidate the
mechanism by which sFasR is neuroprotective.
Dr. K. Boutis
Hospital for Sick Children
Implementation of the Low Risk Ankle Rule.
Ankle injury is a very common injury in children; each year
approximately 35,000 children present to Ontario emergency
departments (ED) with this problem, and 90% of these children
receive x-rays of the injured ankle, even though only 12% of
these x-rays show a break in the bone. Research has created
specific rules that doctors can use to help determine which
children really require x-rays. Unfortunately, even though these
rules have been proven to safely reduce x-rays by as much as
two-thirds, most doctors are not using these rules.
This study will be the first to put the best paediatric ankle
x-ray rule, the Low Risk Ankle Rule, into physician practice in
EDs. The main goal of this study is to determine how much the
ankle x-ray rates can be reduced in EDs that use this rule
regularly versus those that do not. If this study shows that
doctors can safely use this rule and reduce the number of ankle
x-rays, this will lessen unnecessary potentially harmful
radiation exposure in children, and children will spend less time
in the ED, thereby saving health care system resources.
Dr. Y. Yinon
Dr. J. Kingdom
Mount Sinai Hospital
Understanding the mechanisms for increased cardiovascular
risk in women with a history of severe pre-eclampsia - An
assessment of postpartum endothelial function.
Women with a history of pre-eclampsia or intra-uterine growth
restriction (IUGR) face increased risk for the future development
of hypertension and cardiovascular disease. The underlying
mechanism that places women with such a history of increased risk
remains unknown.
The aim of this study is to examine whether endothelial function
is impaired in postpartum women with a history of pre-eclampsia
or IUGR. These investigators will also determine the correlation
between impaired vascular dilation and biochemical markers such
as microalbuminuria and elevated circulatory levels of serum
anti-angiogenic factors (sFlt-1 and sEng). The findings of this
study may introduce new measures to predict future cardiovascular
disease in women with a history of pre-eclampsia/IUGR, and then
translate into early interventions for the prevention of negative
cardiovascular outcomes.
Dr. I. Awad
Sunnybrook Health Sciences Centre
Femoral nerve block: Anatomical insertion point - A
prospective randomised double-blind controlled trial.
Nerve blocks are an effective way to control pain after surgery.
Two major nerves provide sensation to the knee: the femoral nerve
provides sensation to the front of the knee, and the sciatic
nerve provides sensation to the back of the knee.
This study attempts to address a belief that has not been
evaluated scientifically, yet is accepted by practitioners and
teachers of regional anesthesia. Does needle insertion at the
inguinal crease with stimulation of sartorius muscle cause an
equivalent block to the classical method with stimulation of the
quadriceps femoris muscle, for femoral nerve blockade?
Dr. J. Snowdon
Dr. T. Childs
Queen's University
Investigation of the miRNA expression profiles of endometrial
carcinoma.
MicroRNAs are small regulatory molecules present in the cells of
animals, which have been implicated in the development of several
human cancers.
This study will examine the expression profiles of microRNAs in
endometrial cancer, of which endometrioid adenocarcinoma, also
known as type 1 endometrialcarcinoma, is the most common. This
study will assist with characterizing the molecular events
leading to development of endometrial carcinoma. These
investigators may be able to identify unique microRNA expression
profiles that can be used to distinguish endometrial cancer from
normal tissue, while also hoping to identify potential therapies
or novel molecular markers that could be used to diagnose
endometrial cancers at an earlier stage.
Dr. D. Yu
Dr. S. Vanner
Queen's University
Comparison of lactulose hydrogen breath test with
scintigraphic oro-cecal transit study for detection of bacterial
overgrowth in IBS.
Recent studies suggest that most patients with Irritable Bowel
Syndrome (IBS) have undiagnosed intestinal bacterial overgrowth
(SIBO), as determined by lactulose hydrogen breath test (LHBT).
Treatment with antibiotics dramatically improves their symptoms.
The reliability of LHBT for diagnosing SIBO is controversial, yet
this test continues to be recommended and widely used.
Surprisingly, as many as 90% of community gastroenterologists in
the United States are currently prescribing antibiotics for
patients with IBS, based on the finding on a LHBT, despite
concerns about its accuracy.
To gain a more accurate understanding between the association of
SIBO and IBS, it is important to employ complimentary
investigations to better determine if rises in hydrogen in the
LHBT, currently used as a diagnostic test for IBS, could be
secondary to a colonic site of hydrogen production, as opposed to
the small bowel as currently proposed.
The goal of this study is to determine the validity of the LHBT
for diagnosing small bowel bacterial overgrowth, by determining
whether changes in this test occur before of after the test meal
reaches the large bowel. The investigators hypothesize that
abnormalities in the LHBT in IBS patients are due to interaction
with cecal bacteria and not small bowel bacteria.
Dr. P. Szmitko
Dr. S. Verma
St. Michael's Hospital
Role of the tumor suppressor gene BRCA1 in adverse cardiac
remodeling: In Vivo integrative studies in cardiac specific BRCA1
knockout mice.
Heart attacks are a leading cause of death globally; they occur
when the blood and oxygen supply to a part of the heart is
blocked. Heart cells in the damaged areas consequently adapt or
die, potentially resulting in heart failure and ultimately death.
Understanding the signaling pathways governing cardiomyocyte
death may offer therapeutic strategies to limit myocardial
injury, cardiac morbidity and mortality.
The pathophysiological stressors of an evolving heart attack
promote signaling pathways, which lead to myocardial cell
apoptosis. DNA damage is the hallmark of apoptotic cell death.
These investigators plan to determine if BRCA1, a gene that
promotes DNA repair, can protect heart function by reducing heart
cell injury and apoptosis. This is the first project aimed at
studying how the breast cancer gene BRCA1 may be involved in cell
adaptations and survival following heart injury. This work will
improve the understanding of how and why heart disease occurs and
will hopefully pave the way for better therapeutic drug designs.
Dr. K. Levitt
Dr. S. Verma
St. Michael's Hospital
ACE2 and atherosclerosis.
The renin-angiotensin system (RAS) is a clinical mediator of
cardiovascular disease, and an established target in the
treatment of hypertension, after heart failure. Angiotensin-II
(AngII), the main effector molecule of the RAS, is a potent
proinflammatory and proatherosclerotic molecule, and plays an
important role in the development and progression of
cardiovascular disease. Recent evidence suggests that the protein
angiotensin converting enzyme 2 (ACE2) may be involved in
regulating the activities of AngII.
These investigators hypothesize that since ACE2 is found in blood
vessels, it may participate in regulating blood vessel function.
The results of this study may aid in the development of novel
ACE2-based treatment strategies in the treatment of
cardiovascular diseases.